Acute myopathy in a patient with lung adenocarcinoma treated with gemcitabine and docetaxel

Anticancer Research

Volumn 25, Issue 1 B, 2005, Pages 523-525

  Ardavanis, Alexandros S ^a,b   Ioannidis, Georgios N ^a   Rigatos, Gerassimos A ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Docetaxel; Edema; Gemcitabine; Myalgias; Proximal muscle weakness

Indexed keywords

CORTICOSTEROID; DOCETAXEL; GEMCITABINE;

ADULT; ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; DERMATOMYOSITIS; DRUG INDUCED DISEASE; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MALE; MUSCLE WEAKNESS; MYALGIA; MYOPATHY; MYOSITIS; PARANEOPLASTIC SYNDROME; PERIPHERAL EDEMA; POLYNEUROPATHY; PRIORITY JOURNAL; RARE DISEASE; RHABDOMYOLYSIS; RHEUMATIC POLYMYALGIA; SIDE EFFECT; TENOSYNOVITIS;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; DIABETES MELLITUS, TYPE 2; EDEMA; HUMANS; INFLAMMATION; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUSCULAR DISEASES; TAXOIDS;

EID: 16344365256     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Schulman P, Kerr LD and Spiera H: A reexamination of the relationship between myositis and malignancy. J Rheumatol 18(11): 1689-92, 1991.
2. Levin MI, Mozaffar T, Al-Lozi MT et al: Paraneoplastic necrotizing myopathy: clinical and pathologic features. Neurology 50(3): 764-7, 1998.
3. Oh SJ: Praneoplastic vasculitis of the peripheral nervous system. Neurol Clin 75: 849, 1997.
4. Briemberg HR and Amato AA: Neuromuscular complications of cancer. Neurol Clin 21(1): 141-65, 2003.
5. Buchbinder R and Hill CL: Malignancy in patients with inflammatory myopathy. Curr Rheumatol Rep 4(5): 415-26, 2002.
6. Manganelli P, Ferraccioli G and Passalacqua R: Polymyalgia rheumatica and malignant neoplasms. A report of 3 cases. Recent Prog Med 83(4): 200-2, 1992.
7. Gomm SA, Thatcher N, Barber PV et al: A clinicopathological study of the paraneoplastic neuromuscular syndromes associated with lung cancer. Q J Med 75(278): 577-95, 1990.
8. Kelkar P, Masood M and Parry GJ: Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy). Neurology 53: 83, 2000.
9. Chokroverty S, Reyes MG, Rubino FA et al: The syndrome of diabetic amyotrophy. Ann Neurol 2: 131, 1977.
10. Zuckner J: Drug-related myopathies. Rheum Dis Clin North Am 20: 1017, 1994.
11. Fogarty G, Ball D and Rischin D: Radiation recall reaction following gemcitabine. Lung Cancer 33(2-3): 299-302, 2001.
12. Geffen DB and Horowitz J: Gemcitabine- induced severe extremity edema with muscle contractures and subsequent prevention with prednisone. Isr Med Assoc J 2(7): 552-3, 2000.
13. Voorburg AM, van Beek FT, Slee PH et al: Vasculitis due to gemcitabine. Lung Cancer 36(2): 203-5, 2002.
14. Semb KA, Aamdal S and Oian P: Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment. J Clin Oncol 16(10): 3426-32, 1998.
15. Behar A, Pujade-Lauraine E, Maurel A et al: The pathophysiological mechanism of fluid retention in advanced cancer patients treated with docetaxel, but not receiving corticosteroid comedication. Br J Clin Pharmacol 43(6): 653-8, 1997.
16. Azzoli CG, Miller VA, Ng KK et al: Gemcitabine-induced peripheral edema: report on 15 cases and review of the literature. Am J Clin Oncol 26(3): 247-51, 2003.
17. De Pas T, Gurigliano G, Franceschelli L et al: Gemcitabine-induced systemic capillary leak syndrome. Ann Oncol 12(11): 1651-2, 2001.
18. Sica DA: Calcium- channel blocker- related peripheral edema: can it be resolved? J Clin Hypertens (Greenwich) 5(4): 291-4, 297, 2003.